Greenwich LifeSciences, Inc. STAFFORD, Texas, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on ...
Several hedge funds have recently bought and sold shares of the business. Wells Fargo & Company MN grew its position in shares of Greenwich LifeSciences by 54.8% in the fourth quarter. Wells Fargo ...
Deep Track Capital, LP, (together with its affiliates, "Deep Track" or "we"), one of the largest shareholders of Dynavax Technologies Corporation (NASDAQ: DVAX) ("Dynavax", "DVAX" or the "Company"), ...
The BNY Mellon Global Stock Fund underperformed the MSCI World Index for the fourth quarter of 2024. Read more here.
Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...
After years of living out of suitcases and subletting around the city, a young actor decided to put her savings to work and find a "soft place to land." By Matt Yan Fewer Americans are moving ...
South Korea has designated life sciences and biotechnology as priority areas for growth and leadership. The country is experiencing rapid growth in biotechnology thanks to continuous public and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results